Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/1998
11/18/1998CN1199426A Antigenic preparations
11/18/1998CN1199335A Pharmaceutical preparation contg. nimesulide for topical use
11/18/1998CN1198936A Chinese and Western medicine capsule for curing psoriasis and leucodermia in sleep
11/18/1998CN1198935A Acne eliminating pill
11/18/1998CN1040746C New crystalline form of vitamin D analogue
11/17/1998US5837713 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
11/17/1998US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors
11/17/1998US5837697 Containing salicylic acid, sunscreen agent and a carrier
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837274 Polyurethanes for bactericides and phenols for cleaning compounds
11/17/1998US5837266 Composition, barrier film, and method for preventing contact dermatitis
11/17/1998US5837224 Method of inhibiting photoaging of skin
11/12/1998WO1998050530A2 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050055A1 Ointment for the treatment of burns and of other skin diseases
11/12/1998WO1998050050A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
11/12/1998WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998WO1998050014A1 Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
11/12/1998WO1998050013A1 Use of oligosaccharides for the treatment of connective tissues
11/12/1998WO1998050004A1 Ascorbyl-phosphoryl-cholesterol
11/12/1998WO1998050000A2 Cosmetic particulate gel carriers for topically applied active agents
11/12/1998WO1998049897A1 Beta lactams as antiproliferative agents
11/12/1998CA2289705A1 Beta lactams as antiproliferative agents
11/12/1998CA2289041A1 Cosmetic particulate gel carriers for topically applied active agents
11/12/1998CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998CA2288773A1 Use of oligosaccharides for the treatment of connective tissues
11/12/1998CA2288640A1 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/11/1998EP0876813A1 Composition containing a microorganism culture medium
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0876330A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
11/11/1998EP0876157A1 Methods and compositions for passive immunotherapy
11/11/1998EP0876154A1 Using serine-proteases for acne and inflamed comedones
11/11/1998EP0876139A1 Medicament forms constituted in situ for releasing enzymes into wounds
11/11/1998EP0876137A1 Compounds based on squalene and sphingolipids effective against bacteria, parasites, protozoa, fungi and viruses
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834519 Stabilized gas-supersaturated emulsions and suspensions
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834437 Wound healing agents
11/10/1998US5834290 Skin disorders such as acne, xeroderma, hyperkeratotic conditions, callosities and keratosis pilaris; ichthyoses, psoriasis and eczemas; autoimmune pemphigus, acatholytic diseases, familiar pemphigus and darier's disease
11/05/1998WO1998049300A2 Truncated vegf-related proteins
11/05/1998WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048860A1 Dermal sheath tissue in wound healing
11/05/1998WO1998048805A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
11/05/1998WO1998048795A1 Therapeutic treatment for skin disorders
11/05/1998WO1998048772A1 Personal care compositions comprising a silicone-containing adhesive copolymer
11/05/1998WO1998048770A1 Personal care compositions comprising an adhesive copolymer
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998WO1998033798A3 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2289257A1 Therapeutic treatment for skin disorders
11/05/1998CA2288089A1 Hair spray compositions
11/05/1998CA2288039A1 Personal care compositions comprising an adhesive copolymer
11/05/1998CA2287538A1 Truncated vegf-related proteins
11/05/1998CA2287507A1 Dermal sheath tissue in wound healing
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/04/1998EP0875495A1 New derivatives of salicylic acid and their use in cosmetic and/or dermatological compositions
11/04/1998EP0875232A1 A lipid composition containing liquid crystal phase
11/04/1998EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
11/04/1998EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998EP0874813A1 24-homo-26,27-hexafluoro-cholecalciferols
11/04/1998EP0874626A1 Use of inhibitors of retinoic acid activity for wound healing
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/04/1998CN1198090A Use of autologous dermal fibroblasts for repair of skin and soft tissue defects
11/04/1998CN1197638A Amino acid derivatives and active oxygen-resistins agent
11/03/1998US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830507 Biotherapeutic cell-coated microspheres
11/03/1998US5830504 Cooperative combinations of ligands contained within a matrix
11/03/1998US5830461 Methods for promoting wound healing and treating transplant-associated vasculopathy
10/1998
10/29/1998WO1998048012A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998WO1998047866A2 Arylsecocholadiene derivatives
10/29/1998WO1998047861A1 Retinoid-like compounds
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998WO1998047372A1 In-situ generation of zinc pyrithione
10/29/1998CA2287445A1 Arylsecocholadiene derivatives
10/29/1998CA2287429A1 In-situ generation of zinc pyrithione
10/29/1998CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998CA2286548A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998CA2286252A1 Retinoid-like compounds
10/28/1998EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0873121A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
10/28/1998EP0873112A1 Skin care composition
1 ... 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 ... 1065